S&P 500 7,386.46 â–ŧ 197.85 (-2.61%) DOW 50,883.62 â–ŧ 678.31 (-1.32%) NASDAQ 25,729.81 â–ŧ 1,101.15 (-4.10%) US Markets Open â€ĸ 03:12 PM ET

BUGDF

Bumrungrad Hospital Public Company Limited

Price Chart
Latest Quote

$5.40

+0.65 (+13.68%)
Current Price
Previous Close $4.75
Open $5.40
Day High $5.40
Day Low $5.40
Volume 2,000
Fetched: 2026-06-05T19:12:32
Stock Information
Note: Financial values converted from THB to USD
Quarterly Dividend / Yield $0.15 / 3.25%
Shares Outstanding 794.97M
Quarterly Dividend Yield 3.25%
Quarterly Dividend $0.15
Total Debt $3.16M
Cash Equivalents $437.20M
Revenue $777.14M
Net Income $230.73M
Sector Healthcare
Industry Medical Care Facilities
Market Cap $4.29B
P/E Ratio 20.00
EPS (TTM) $0.27
Exchange PNK
🌐 Visit Website
📊 Comprehensive Analysis
Company Data
Enterprise Value$-10.14B
Sales$777.14M
Income$230.73M
Book/sh$1.25
Cash/sh$18.04
Financial Ratios
Quick Ratio4.37
Current Ratio4.48
Debt/Eq0.31
EPS Growth TTM3.20%
Returns & Margins
ROA15.71%
ROE24.38%
Gross Margin52.40%
Operating Margin34.70%
Profit Margin29.69%
Ownership
Institutional Ownership9.48%
Insider & Institutional transactions data not available
Valuation Ratios
PEG4.00
P/S0.17
P/B4.31
Analyst Data
Recommendationnone
Technical Indicators
SMA20$4.75
SMA50$4.75
SMA200$4.61
RSInan
Shares Float713.11M
Volatility0.23
Performance History
Week+0.00%
Month+0.00%
Quarter+0.00%
6 Months+12.29%
YTD-12.04%
Year-23.60%
3 Years-28.64%
5 Years+24.63%
10 Years-3.99%
Stock Score: ⭐ Premium
Based on debt, profitability, growth, and cash flow metrics
⭐ Premium Feature

Sign up for free to view detailed scoring breakdown — premium is free during our trial period!

Recent Price History
Date Close Volume
2026-06-04 $4.75 0
2026-06-03 $4.75 0
2026-06-02 $4.75 0
2026-06-01 $4.75 0
2026-05-29 $4.75 0
2026-05-28 $4.75 0
2026-05-27 $4.75 0
2026-05-26 $4.75 0
2026-05-22 $4.75 0
2026-05-21 $4.75 0
2026-05-20 $4.75 0
2026-05-19 $4.75 0
2026-05-18 $4.75 0
2026-05-15 $4.75 0
2026-05-14 $4.75 0
2026-05-13 $4.75 0
2026-05-12 $4.75 0
2026-05-11 $4.75 0
2026-05-08 $4.75 0
2026-05-07 $4.75 0
2026-05-06 $4.75 0
2026-05-05 $4.75 0
About Bumrungrad Hospital Public Company Limited

Bumrungrad Hospital Public Company Limited owns and operates hospitals and healthcare centers in Thailand and internationally. It offers services in the areas of allergy, arrhythmia, behavioural health, breast, home, heart valve, robotic surgery, rehabilitation, spine, pediatrics, colorectal surgery, complex coronary artery intervention, comprehensive sleep, cornea transplant, dental, diagnostic, dialysis, radiology and nuclear medicine, digestive disease, ear, nose, throat, emergency, endocrinology, esperance, diabetes, expatriate liaison, eye, fertility, gastrointestinal motility, health screening, holistic wound care, horizon regional cancer, hyperbaric oxygen therapy, nephrology, neuroscience, orthopaedics, perinatal, plastic surgery, pulmonary, refractive surgery, memory, robotic scoliosis, skin, sports medicine and joint, surgery, travel medicine, urology, scientific wellness, skin and aesthetic, and women's centers. The company also operates breastfeeding, Yangon, COVID-19 recovery, IVF, hearing and balance, medical, new life healthy aging, Parkinson's disease and movement disorders, pride, surgery, and vaccine clinics and centers. In addition, it operates spine institute, heart institute, and intensive care unit; and offers nutrition services, pharmacy services, preventive genomics and integrative medicine services. Bumrungrad Hospital Public Company Limited was founded in 1975 and is based in Bangkok, Thailand.

Period:
Loading...
Income Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Revenue
Reconciled Cost Of Revenue $396,670,165 $409,099,788 $352,133,862 $245,272,215
Cost Of Revenue $396,670,165 $409,099,788 $352,133,862 $245,272,215
Total Revenue $815,912,952 $805,081,139 $657,378,261 $395,317,907
Operating Revenue $815,912,952 $805,081,139 $657,378,261 $395,317,907
Expenses
Interest Expense $264,429 $75,938 $112,525 $3,799,362
Total Expenses $524,413,284 $536,301,264 $466,695,253 $345,266,192
Rent Expense Supplemental $2,719,511 $2,253,521 $1,462,944 -
Other Income Expense $-734,812 $861,622 $-119,944 $-2,245,527
Net Non Operating Interest Income Expense $8,602,107 $4,395,777 $1,345,415 $-1,617,113
Interest Expense Non Operating $264,429 $75,938 $112,525 $3,799,362
Operating Expense $127,743,119 $127,201,475 $114,561,391 $99,993,977
Other Operating Expenses $-4,596,212 $-5,417,559 $-5,931,763 $-4,571,561
Selling And Marketing Expense $23,108,162 $21,728,416 $18,601,958 $11,372,019
General And Administrative Expense $109,231,170 $110,890,618 $101,891,197 $93,193,519
Income & Earnings
Net Income From Continuing Operation Net Minority Interest $246,660,075 $222,285,872 $156,669,468 $38,568,470
Net Interest Income $8,602,107 $4,395,777 $1,345,415 $-1,617,113
Interest Income $8,866,536 $4,471,715 $1,457,940 $2,182,249
Normalized Income $247,258,728 $221,558,858 $156,754,841 $40,145,518
Net Income From Continuing And Discontinued Operation $246,660,075 $222,285,872 $156,669,468 $38,568,470
Total Operating Income As Reported $290,778,412 $269,669,965 $190,579,243 $48,200,158
Net Income Common Stockholders $246,660,075 $222,285,872 $156,669,468 $38,568,470
Net Income $246,660,075 $222,285,872 $156,669,468 $38,568,470
Net Income Including Noncontrolling Interests $248,478,955 $223,830,310 $157,892,194 $39,341,140
Net Income Continuous Operations $248,478,955 $223,830,310 $157,892,194 $39,341,140
Pretax Income $299,366,963 $274,037,275 $191,908,478 $46,189,074
Earnings From Equity Interest $-13,556 $-28,467 $-16,179 $-393,970
Interest Income Non Operating $8,866,536 $4,471,715 $1,457,940 $2,182,249
Operating Income $291,499,668 $268,779,875 $190,683,008 $50,051,715
Gross Profit $419,242,787 $395,981,351 $305,244,399 $150,045,692
Special Income Charges - - $0 $-1,790,867
Per Share
Diluted EPS $0.28 $0.26 $0.18 $0.04
Basic EPS $0.31 $0.28 $0.20 $0.05
Other
Tax Effect Of Unusual Items $-122,603 $163,075 $-18,393 $-274,510
Tax Rate For Calcs $0 $0 $0 $0
Normalized EBITDA (Bullshit earnings) $334,528,916 $308,019,061 $227,558,619 $89,274,054
Total Unusual Items $-721,256 $890,090 $-103,765 $-1,851,557
Total Unusual Items Excluding Goodwill $-721,256 $890,090 $-103,765 $-1,851,557
Reconciled Depreciation $34,176,268 $34,795,938 $35,433,850 $37,434,060
EBITDA (Bullshit earnings) $333,807,660 $308,909,150 $227,454,853 $87,422,497
EBIT $299,631,392 $274,113,213 $192,021,003 $49,988,436
Diluted Average Shares $27,519,510 $27,519,510 $27,519,510 $27,519,510
Basic Average Shares $25,219,257 $25,218,463 $25,216,941 $25,208,946
Diluted NI Availto Com Stockholders $246,660,075 $222,285,872 $156,669,468 $38,568,470
Minority Interests $-1,818,880 $-1,544,437 $-1,222,726 $-772,670
Tax Provision $50,888,008 $50,206,965 $34,016,284 $6,847,935
Gain On Sale Of Security $-721,256 $890,090 $-103,765 $-60,690
Selling General And Administration $132,339,332 $132,619,034 $120,493,154 $104,565,538
Other Gand A $109,231,170 $110,890,618 $101,891,197 $93,193,519
Gain On Sale Of Business - - $0 $-1,790,867
Fetched: 2026-02-06
Balance Sheet (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Assets
Net Tangible Assets $851,511,030 $733,822,260 $602,669,910 $523,322,058
Total Assets $1,035,946,805 $926,779,950 $769,632,313 $661,700,629
Total Non Current Assets $505,124,177 $429,160,135 $407,361,455 $405,927,252
Other Non Current Assets $2,487,638 $2,992,233 $1,939,857 $2,293,776
Non Current Deferred Assets $9,870,259 $9,810,679 $9,544,482 $10,503,240
Non Current Deferred Taxes Assets $9,870,259 $9,810,679 $9,544,482 $10,503,240
Non Current Note Receivables $0 $0 $0 $0
Investmentin Financial Assets $63,881,716 $2,266,529 $7,329 $7,329
Goodwill And Other Intangible Assets $20,559,996 $21,289,658 $22,504,422 $25,095,325
Other Intangible Assets $18,653,521 $19,367,924 $20,576,966 $22,842,226
Current Assets $530,822,628 $497,619,815 $362,270,858 $255,773,377
Other Current Assets $4,797,769 $1,734,952 $839,652 $7,155,044
Prepaid Assets $4,080,522 $3,619,534 $4,196,266 $3,561,178
Inventory $11,292,492 $11,492,907 $10,334,372 $10,392,019
Receivables $126,342,698 $139,862,558 $84,331,944 $46,353,075
Other Receivables $2,166,783 $1,753,839 $578,458 $580,298
Accounts Receivable $121,421,600 $135,328,516 $83,753,486 $45,772,460
Allowance For Doubtful Accounts Receivable $-6,122,081 $-7,642,512 $-6,935,215 $-7,071,383
Gross Accounts Receivable $127,543,681 $142,971,028 $90,688,702 $52,843,843
Cash Cash Equivalents And Short Term Investments $384,309,147 $340,909,864 $262,568,625 $188,312,060
Cash And Cash Equivalents $103,406,825 $119,735,207 $66,342,840 $57,170,885
Cash Equivalents $102,683,498 $118,987,432 $65,728,900 $56,764,592
Cash Financial $723,318 $747,779 $613,928 $406,282
Financial Assets Designatedas Fair Value Through Profitor Loss Total - $2,259,200 $0 -
Debt
Total Debt $4,423,987 $2,891,633 $2,007,662 $2,994,114
Long Term Debt And Capital Lease Obligation $3,247,316 $2,353,546 $1,259,598 $1,709,580
Long Term Debt $770,325 $768,427 $766,065 $736,818
Current Debt And Capital Lease Obligation $1,176,671 $538,087 $748,064 $1,284,534
Liabilities
Total Liabilities Net Minority Interest $153,937,608 $162,256,234 $134,945,851 $102,755,940
Total Non Current Liabilities Net Minority Interest $32,531,232 $29,503,970 $26,602,962 $30,287,179
Non Current Deferred Liabilities $91,951 $67,511 $51,536 $151,234
Non Current Deferred Taxes Liabilities $91,951 $67,511 $51,536 $151,234
Current Liabilities $121,406,376 $132,752,265 $108,342,889 $72,468,761
Other Current Liabilities $6,849,803 $5,595,400 $4,511,522 $8,415,929
Payables And Accrued Expenses $113,379,902 $126,618,778 $103,083,303 $62,768,299
Payables $53,113,781 $59,697,743 $53,991,176 $29,919,832
Other Payable $6,214,054 $4,949,936 $6,798,445 $4,001,427
Total Tax Payable $16,668,542 $25,481,596 $19,564,465 $4,379,224
Income Tax Payable $16,668,542 $25,481,596 $19,564,465 $4,379,224
Accounts Payable $30,231,185 $29,266,211 $27,628,267 $21,539,181
Equity
Common Stock Equity $872,044,041 $755,083,981 $625,146,389 $548,379,919
Preferred Stock Equity $26,985 $27,937 $27,943 $37,464
Total Equity Gross Minority Interest $882,009,197 $764,523,716 $634,686,462 $558,944,689
Stockholders Equity $872,071,026 $755,111,918 $625,174,332 $548,417,383
Other Equity Interest $10,152,284 $10,152,284 $10,152,284 $10,152,284
Gains Losses Not Affecting Retained Earnings $-4,830,050 $-5,103,457 $-6,832,274 $-4,257,775
Other Equity Adjustments $3,150,735 $2,792,063 $2,792,063 $2,792,063
Retained Earnings $827,230,376 $710,544,675 $582,335,906 $503,004,458
Long Term Equity Investment $4,132,738 $418,502 $46,853 $45,619
Other
Ordinary Shares Number $25,219,413 $25,218,462 $25,218,455 $25,208,934
Share Issued $25,219,413 $25,218,462 $25,218,455 $25,208,934
Tangible Book Value $851,484,045 $733,794,324 $602,641,967 $523,284,594
Invested Capital $872,814,366 $755,852,408 $625,912,453 $549,116,737
Working Capital $409,416,252 $364,867,551 $253,927,969 $183,304,616
Capital Lease Obligations $3,653,662 $2,123,206 $1,241,598 $2,257,296
Total Capitalization $872,841,351 $755,880,345 $625,940,397 $549,154,201
Minority Interest $9,938,171 $9,411,798 $9,512,130 $10,527,306
Foreign Currency Translation Adjustments $-7,980,784 $-7,895,520 $-9,624,337 $-7,049,838
Additional Paid In Capital $14,272,018 $14,272,018 $14,272,018 $14,272,018
Capital Stock $25,246,398 $25,246,398 $25,246,398 $25,246,398
Common Stock $25,219,413 $25,218,462 $25,218,455 $25,208,934
Preferred Stock $26,985 $27,937 $27,943 $37,464
Employee Benefits $29,191,965 $27,082,912 $25,291,828 $28,426,364
Long Term Capital Lease Obligation $2,476,991 $1,585,119 $493,534 $972,762
Current Capital Lease Obligation $1,176,671 $538,087 $748,064 $1,284,534
Current Accrued Expenses $60,266,120 $66,921,035 $49,092,127 $32,848,466
Dueto Related Parties Current $0 $0 $0 $0
Investments And Advances $68,014,454 $2,685,031 $54,182 $52,948
Available For Sale Securities $63,881,716 $7,329 $7,329 $7,329
Investmentsin Joint Venturesat Cost $4,127,066 $411,217 $0 -
Investmentsin Associatesat Cost $5,672 $7,286 $46,853 $45,619
Investmentsin Subsidiariesat Cost $0 $0 $0 $0
Goodwill $1,906,475 $1,921,733 $1,927,456 $2,253,099
Net PPE $404,191,830 $392,382,534 $373,318,512 $367,981,964
Accumulated Depreciation $-445,017,494 $-430,122,063 $-412,781,360 $-391,758,677
Gross PPE $849,209,324 $822,504,598 $786,099,872 $759,740,641
Construction In Progress $37,896,731 $36,975,665 $30,623,063 $38,505,804
Other Properties $327,738,311 $314,817,531 $307,823,908 $289,791,168
Machinery Furniture Equipment $26,550,062 $24,018,241 $23,157,835 $23,201,458
Buildings And Improvements $277,342,311 $267,008,904 $254,751,195 $245,424,419
Land And Improvements $179,681,909 $179,684,256 $169,743,870 $162,817,791
Properties $0 $0 $0 $0
Other Inventories $12 $14 $13 $15
Finished Goods $5,764,911 $6,015,070 $5,318,433 $5,351,110
Raw Materials $5,527,570 $5,477,823 $5,015,926 $5,040,894
Duefrom Related Parties Current $2,754,315 $2,780,203 $0 $317
Other Short Term Investments $280,902,321 $221,174,658 $196,225,785 $131,141,175
Preferred Shares Number - $27,937 $27,943 $37,464
Held To Maturity Securities - $2,259,200 $0 -
Fetched: 2026-02-06
Cash Flow Statement (Annual)
Metric 2024-12-31 2023-12-31 2022-12-31 2021-12-31
Free Cash Flow
Free Cash Flow $233,192,808 $171,926,385 $158,376,134 $82,072,229
Operating Activities
Operating Cash Flow $275,102,739 $225,075,005 $197,100,952 $112,822,266
Cash Flow From Continuing Operating Activities $275,102,737 $225,074,991 $197,100,962 $112,822,266
Operating Gains Losses $4,216,007 $2,004,767 $4,410,604 $5,802,885
Investing Activities
Capital Expenditure $-41,909,931 $-53,148,620 $-38,724,818 $-30,750,037
Investing Cash Flow $-158,149,532 $-77,049,301 $-102,237,322 $71,448,690
Cash Flow From Continuing Investing Activities $-158,149,532 $-77,049,301 $-102,237,322 $71,448,690
Financing Activities
Financing Cash Flow $-134,016,463 $-96,789,115 $-84,267,513 $-166,733,727
Cash Flow From Continuing Financing Activities $-134,016,463 $-96,789,115 $-84,267,513 $-166,733,727
Net Other Financing Charges $-1,718,884 $-1,724,281 $-1,290,012 $-376,140
Cash Dividends Paid $-130,115,898 $-93,225,251 $-80,667,916 $-80,738,105
Dividends Received Cfi $0 $0 $0 $0
Other
Repayment Of Debt $-1,222,627 $-881,461 $-1,351,463 $-80,719,418
End Cash Position $103,406,825 $119,735,207 $66,342,840 $57,170,885
Beginning Cash Position $119,735,207 $66,342,840 $57,170,885 $39,004,565
Effect Of Exchange Rate Changes $734,874 $2,155,777 $-1,424,164 $629,091
Changes In Cash $-17,063,256 $51,236,590 $10,596,118 $17,537,229
Interest Paid Cff $-959,054 $-958,122 $-958,122 $-4,900,063
Net Issuance Payments Of Debt $-1,222,627 $-881,461 $-1,351,463 $-80,719,418
Net Long Term Debt Issuance $-1,222,627 $-881,461 $-1,351,463 $-80,719,418
Long Term Debt Payments $-1,222,627 $-881,461 $-1,351,463 $-80,719,418
Interest Received Cfi $6,657,697 $3,652,002 $1,388,657 $2,608,806
Net Investment Purchase And Sale $-120,519,842 $-27,208,083 $-65,084,588 $99,338,246
Sale Of Investment $307,120,283 $171,774,702 $121,021,037 $194,947,460
Purchase Of Investment $-427,640,125 $-198,982,785 $-186,105,626 $-95,609,215
Net Business Purchase And Sale $-3,727,792 $-530,979 $-15,863 $176,459
Purchase Of Business $-3,727,792 $-530,979 $-15,863 $0
Net Intangibles Purchase And Sale $-3,317,451 $-3,269,489 $-2,367,969 $-5,271,973
Purchase Of Intangibles $-3,317,451 $-3,269,489 $-2,367,969 $-5,271,973
Net PPE Purchase And Sale $-37,242,144 $-49,692,752 $-36,157,560 $-25,402,848
Sale Of PPE $1,350,335 $186,379 $199,290 $75,216
Purchase Of PPE $-38,592,480 $-49,879,131 $-36,356,850 $-25,478,064
Taxes Refund Paid $-60,113,360 $-44,781,874 $-19,039,336 $-3,289,076
Change In Working Capital $6,535,792 $-37,343,957 $-14,700,447 $23,318,504
Change In Other Current Liabilities $1,254,404 $1,083,875 $-3,904,398 $5,297,911
Change In Other Current Assets $-1,302,966 $823,204 $6,863,742 $-6,672,258
Change In Payables And Accrued Expense $-5,649,512 $18,375,283 $23,074,105 $4,150,711
Change In Accrued Expense $-6,910,235 $17,760,133 $16,156,374 $-1,047,551
Change In Payable $1,260,723 $615,150 $6,917,731 $5,198,262
Change In Prepaid Assets $-460,988 $576,732 $-635,088 $-156,099
Change In Inventory $229,292 $-1,103,070 $-25,373 $-585,478
Change In Receivables $12,465,562 $-57,099,980 $-40,073,434 $21,283,717
Other Non Cash Items $-9,758,983 $-6,149,590 $-2,976,065 $893,791
Unrealized Gain Loss On Investment Securities $-374,675 $0 - -
Provisionand Write Offof Assets $1,054,296 $2,537,645 $1,986,140 $2,444,283
Asset Impairment Charge $433 $-25,199 $77,729 $28,744
Depreciation Amortization Depletion $34,176,268 $34,795,938 $35,433,850 $37,434,060
Depreciation And Amortization $34,176,268 $34,795,938 $35,433,850 $37,434,060
Amortization Cash Flow $3,616,910 $4,432,646 $4,798,889 -
Amortization Of Intangibles $3,616,910 $4,432,646 $4,798,889 -
Depreciation $30,559,358 $30,363,292 $30,634,961 -
Pension And Employee Benefit Expense $4,385,556 $3,773,757 $4,000,873 $3,834,422
Earnings Losses From Equity Investments $13,556 $28,467 $16,179 $393,970
Gain Loss On Sale Of PPE $-183,105 $-1,797,458 $393,552 $-216,374
Net Income From Continuing Operations $299,366,963 $274,037,275 $191,908,478 $46,189,074
Sale Of Business - - $0 $176,459
Gain Loss On Sale Of Business - - $0 $1,790,867
Fetched: 2026-02-06